However, some studies showed that IRF2 plays a tumor suppressor role in HBV or HCV associated HCC, and IRF2 silencing significantly increased cell proliferation by impairing the function of TP53 [33], which may be caused by the heterogeneity of tumor cells. The gene discussed is TP53; the disease is hepatocellular carcinoma.